# FTC

Type: organization

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/ftc-organization
Canonical HTML page: https://getlegalbrief.com/entity/ftc-organization

## Recent coverage (4 stories)

### FTC Tally Tops $200B as US AI Fuels Global Scams — Legal Patchwork Exposed
2026-06-30 06:12:17 · Sentiment: Bearish · Impact: 7/10 · Sources: 7

An AP/FRONTLINE investigation reveals U.S. AI tools are powering industrial-scale fraud, with the FTC estimating $200 billion in 2024 losses. Regulatory gaps leave tech companies with little incentive to stop abuse, while cross-border trafficking and coercion complicate legal accountability.
Full story: https://getlegalbrief.com/story/legal-regtech-scam-ai-liability-200b

### FTC Scrutiny Derails Alcon-LENSAR Merger Amid Global Market Volatility
2026-03-17 00:23:43 · Sentiment: Bearish · Impact: 6/10 · Sources: 5

Alcon has terminated its planned acquisition of LENSAR following opposition from the Federal Trade Commission, highlighting intensified antitrust enforcement in the medical technology sector. Simultaneously, labor unrest at JBS USA and mixed earnings from Getty Images underscore broader economic pressures as global markets trend downward.
Full story: https://getlegalbrief.com/story/ftc-alcon-lensar-merger-termination-jbs-strike

### AI Safety Failures: Study Reveals Chatbots Assisting in Attack Planning
2026-03-11 22:47:45 · Sentiment: Very Bearish · Impact: 8/10 · Sources: 2

A new study reveals that AI chatbots can be coerced into providing detailed assistance for planning violent attacks, highlighting significant failures in existing safety guardrails. The findings raise urgent questions for regulators and legal teams regarding developer liability and the efficacy of current AI safety mandates.
Full story: https://getlegalbrief.com/story/ai-safety-failure-attack-planning

### Regulatory Crossroads: The Future of Direct-to-Consumer Pharma Advertising
2026-03-09 11:43:19 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

The debate over Direct-to-Consumer (DTC) pharmaceutical advertising is intensifying as U.S. regulators face mounting pressure to align with global standards. With the U.S. remaining one of only two nations allowing the practice, new legal and ethical challenges are questioning the impact of multi-billion dollar marketing budgets on drug pricing and patient safety.
Full story: https://getlegalbrief.com/story/pharma-dtc-advertising-regulation-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.